Skip to main content
. 2017 Apr 4;124(8):915–964. doi: 10.1007/s00702-017-1717-8

Table 3.

Diagnostic accuracy of the quantitative assessment of regional cerebral atrophy including MR-planimetry, -volumetry, and automated methods for quantitative MRI analysis for the diagnosis of APD

References Cohort size Magnetic field Main results Discriminator Accuracy, %
Schulz et al. (1999) MSA-P 12/MSA-C 17/PD 11/PSP 6/HC 16 1.5 T ↓ Mean striatal and brainstem volumes in MSA-P, MSA-C, and PSP
↓ Cerebellar volume in MSA-C and MSA-P
Volumes were TIV-corrected
Patients with PD could not be separated from HC and patients with MSA-P could not be separated from patients with PSP
Discriminant function including volumes of brainstem, caudate nucleus, putamen, and cerebellum (stepwise linear discrimination)a Overall correct classification 65%
91% of APD and 89% of non-APD classified correctly
75% of PD, 36% of HC, 67% of MSA-P, 76% of MSA-C and 50% of PSP classified correctly
Se 76 (MSA-C)
Sp 100 (vs. PD), 82 (vs. HC), 100 (vs. PSP)
Cordato et al. (2002) PSP 21/PD 17/HC 23 1.5 T ↑ Ventricular volume, ↓ whole brain and frontal GM volumes in PSP vs. PD and HC Frontal GM volume Se 95 (PSP)
Sp 91 (vs. other groups)
Groschel et al. (2004) PSP 33/CBS 18/HC 22 (including 8 PSP and 7 CBD with a post-mortem confirmed diagnosis) ↓ Brainstem volume (>midbrain) in PSP vs. CBS and HC
↓ Parietal and occipital lobes volumes (>white matter) in CBS vs. PSP and HC
↓ Area of CC in CBS vs. PSP and HC
Volumes were TIV-corrected
Discriminant function including midbrain, parietal WM, temporal GM, brainstem, frontal WM, and pons volumes Overall correct classification 84%
95% of HC, 76% of CBS, 83% of PSP classified correctly
Paviour et al. (2005) PSP 19/MSA 10/PD 12/HC 12 1.5 T ↓ SCP volume in PSP vs. MSA, PD, and HC
Volumes were TIV-corrected
SCP volume Se 74 (PSP)
Sp 77 (vs. other groups)
Paviour et al. (2006b) MSA-P 9/PSP 18/PD 9/HC 18 1.5 T ↓ Midbrain and SCP volumes in PSP compared to MSA-P, PD and HC
↓ Frontal volume in PSP compared to PD and HC, but not to MSA-P
Significant greater third ventricle in PSP compared to HC, but not to MSA-P and PD
↓ Cerebellar, pontine, and posterior inferior volumes in MSA-P compared to PD and HC
↓ Midbrain volume in MSA-P compared to HC
No significant differences between PD and HC
Midbrain, SCP, frontal, third ventricle, and whole brain volumes Se 89 (PSP)b
Sp 97 (vs. MSA-P, PD, and HC)
SCP, midbrain, pons, and cerebellar volumes Se 94 (PSP)b
Sp 89 (vs. MSA-P)
Cosottini et al. (2007) PSP 15/MSA-P 7/HC 14 1.5 T ↓ md in PSP vs. HC, but is not significantly different between PSP and MSA-p patients
↓ ma in PSP vs. MSA-P and HC
↓ Midbrain volume in PSP patients vs. HC, but does not differ with respect to MSA-P
↓ pa in MSA-P vs. PSP and HC
↓ ma/pa ratio is in PSP vs. MSA-P and HC
↑ ma/pa ratio in MSA-P vs. HC
md Se 60 (PSP vs. MSA-P and HC)
Sp 95 (vs. MSA-P and HC)
AUC = 0.81
Se 60 (PSP vs. MSA-P)
Sp 86 (PSP vs. MSA-P)
AUC = 0.62 (PSP vs. MSA-P)
ma Se 100 (PSP vs. MSA-P and HC)
Sp 90 (PSP vs. MSA-P and HC)
AUC = 0.99
Se 87 (PSP vs. MSA-P)
Sp 100 (PSP vs. MSA-P)
AUC = 0.97
pa Se 73 (PSP vs. MSA-P and HC)
Sp 62 (PSP vs. MSA-P and HC)
AUC = 0.54
Se 100 (PSP vs. MSA-P)
Sp 86 (PSP vs. MSA-P)
AUC = 0.96
ma/pa ratio Se 87 (PSP vs. MSA-P and HC)
Sp 100 (PSP vs. MSA-P and HC)
AUC = 0.96
Se 100 (PSP vs. MSA-P)
Sp 100 (PSP vs. MSA-P)
AUC = 1.00
Midbrain volume Se 87 (PSP vs. MSA-P and HC)
Sp 76 (PSP vs. MSA-P and HC)
AUC = 0.83
Se 87 (PSP vs. MSA-P)
Sp 71 (PSP vs. MSA-P)
AUC = 0.77
Lee et al. (2013b) PD 29/PSP 13/MSA-P 15/HC 21 3.0 T ↓ Volume of caudate, putamen, globus pallidus, and thalamus in PSP and MSA-P vs. PD and HC
↓ Volume of globus pallidus in PSP vs. MSA-P
↓ Volume of putamen in MSA-P vs. PSP
↑ R2* in the putamen in MSA-P vs. PD and HC
↑ R2* in globus pallidus and caudate in PSP vs. PD and HC
↑ R2* in caudate nucleus in PSP vs. MSA-P
Putaminal volume AUC = 0.83 (MSA-P vs. PD and PSP)
Volume of globus pallidus AUC = 0.86 (PSP vs. PD and MSA-P)
Baudrexel et al. (2014) PD 13/PSP 8/MSA-P 11/HC 6 3.0 T ↓ Putaminal volume in MSA-P vs. PD, PSP, and HC Putaminal volume Se 54.5 (MSA-P)
Sp 100 (vs. other groups)
AUC = 0.84
Zanigni et al. (2016) PSP-RS 23/PD 42 1.5 T ↑ Sagittal MCPd/coronal SCPd ratio, pa/maratio, and MRPI in PSP-RS vs. PD
↓ Sagittal MCPd, coronal SCPd, pa, and ma in PSP-RS vs. PD
↑ DTI MD in SCP, thalamus, putamen, globus pallidus, parieto-occipital WM, pre-frontal WM, right brain emisphere, left brain hemisphere, posterior fossa, brainstem, and in cerebellar hemispheres in PSP-RS vs. PD
↓ DTI FA in SCP, midbrain, parieto-occipital WM, pre-frontal WM, right brain hemisphere, left brain hemisphere, posterior fossa, and in brainstem in PSP-RS vs. PD
↓ Volume of brainstem, globus pallidus, putamen and thalamus in PSP-RS vs. PD
↑ Volume of lateral ventricles in PSP-RS vs. PD
ma Se 96 (PSP-RS)
Sp 98
AUC = 0.99
pa/ma-ratio Se 96 (PSP-RS)
Sp 90
AUC = 0.97
MRPI Se 87 (PSP-RS)
Sp 93
AUC = 0.95
Coronal SCPd Se 81 (PSP-RS)
Sp 74
AUC = 0.84
Pons area Se 87 (PSP-RS)
Sp 74
AUC = 0.82
MD SCP Se 70 (PSP-RS)
Sp 98
AUC = 0.88
MD pre-frontal WM Se 90 (PSP-RS)
Sp 69
AUC = 0.86
MD thalamus Se 70 (PSP-RS)
Sp 86
AUC = 0.84
MD putamen Se 80 (PSP-RS)
Sp 71
AUC = 0.82
MD posterior fossa Se 80 (PSP-RS)
Sp 83
AUC = 0.90
MD cerebellar hemispheres Se 80 (PSP-RS)
Sp 74
AUC = 0.86
MD right brain hemisphere Se 75 (PSP-RS)
Sp 90
AUC = 0.88
MD left brain hemisphere Se 65 (PSP-RS)
Sp 95
AUC = 0.87
MD brainstem Se 85 (PSP-RS)
Sp 67
AUC = 0.80
FA SCP Se 75 (PSP-RS)
Sp 80
AUC = 0.82
FA parieto-occipital WM Se 75 (PSP-RS)
Sp 80
AUC = 0.82
FA right brain hemisphere Se 75 (PSP-RS)
Sp 90
AUC = 0.88
FA left brain hemisphere Se 65 (PSP-RS)
Sp 95
AUC = 0.87
FA posterior fossa Se 83 (PSP-RS)
Sp 75
AUC = 0.80
Volume thalamus Se 73 (PSP-RS)
Sp 90
AUC = 0.83
Volume putamen Se 93 (PSP-RS)
Sp 70
AUC = 0.83
Volume globus pallidus Se 93 (PSP-RS)
Sp 60
AUC = 0.81
Oba et al. (2005) PSP 21/MSA-P 25/PD 23/HC 31 1.5 T ↓ ma in PSP vs. PD and MSA-P
↓ pa in MSA-p vs. PD and PSP
↓ In ma/pa-ratio in PSP vs. PD and MSA-P
ma Se 100 (PSP)
Sp 91 (PSP vs. non-PSP)
ma/pa-ratio Se 100 (PSP)
Sp 100 (PSP vs. non-PSP)
Gama et al. (2010) PSP 20/MSA-P 8/MSA-C 11/PD 21/ 1.5 T ↓ ma in PSP and MSA-P vs. PD, in PSP vs. MSA-C and MSA-P, and in MSA-P vs. MSA-C
↓ pa in PSP, MSA-P, and MSA-C vs. PD, and in MSA-C and MSA-P vs. PSP
↓ MCPd in PSP, MSA-C, and MSA-P vs. PD, and in MSA-C vs. PSP
↓ SCPd in PSP and MSA-C vs. PD, and in PSP vs. MSA-C and MSA-P
ma Se 95 (PSP)b
Sp 97 (PSP vs. other groups)
SCPd Se 80 (PSP)
Sp 100 (vs. other groups)
Quattrone et al. (2008) MSA-P 19/PD 108/PSP 33/HC 50 1.5 T ↓ ma and SCPd in PSP compared to PD, MSA-P, and HC with some overlap of values between groups
↑ pa/ma and MCPd/SCPd ratios in PSP compared to PD, MSA-P, and HC with some overlap of values between groups
↑ MRPI in PSP compared to PD, MSA-P, and HC without any overlaps values among groups
pa/ma ratio Se 95 (PSP)b
Sp 97 (vs. PD, MSA-P, and HC)
MCPd/SCPdratio Se 90 (PSP)b
Sp 94 (vs. PD, MSA-P, and HC)
MRPI Se 100 (PSP)b
Sp 100 (vs. PD, MSA-P, and HC)
Hussl et al. (2010) MSA-P 26/PSP 22/PD 75 1.5 T ↓ ma/pa-ratio and ↑ MRPI values in PSP compared to MSA-P, PD, and HC ma/pa ratio Se 64 (PSP)b
Sp 92 (vs. non-PSP), 95 (vs. PD), 85 (vs. MSA-P)
MRPI Se 82 (PSP)b
Sp 80 (vs. non-PSP), 76 (vs. PD), 92 (vs. MSA-P)
Longoni et al. (2011) PSP-RS 10/ PSP-P 10/ PD 25/HC 24 1.5 T ↑ pa/ma ratio in PSP-RS and PSP-P vs. PD
↑ MRPI in PSP-RS and PSP-P vs. PD
pa/ma ratio Se 90 (PSP-RS vs. PD)
Sp 96 (PSP-RS vs. PD)
Se 60 (PSP-P vs. PD)
Sp 96 (PSP-P vs. PD)
MRPI Se 100 (PSP-RS vs. PD)
Sp 92 (PSP-RS vs. PD)
Se 70 (PSP-P vs. PD)
Sp 68 (PSP-P vs. PD)
Morelli et al. (2011a) 81 with clinically uncertain parkinsonism (of which n = 15 developed PSP and n = 11 patients developed MSA) 1.5 T ↑ MRPI in clinically uncertain parkinsonism in those patients developing PSP at follow-up compared to the other patients
MRPI showed a higher accuracy in predicting PSP (92.9%) than clinical features
MRPI Se 100 (PSP)
Sp 90(PD and MSA)
Nigro et al. (2016) PSP 88/PD 234/HC 117 1.5 T ↑ MRPI in PSP vs. PD and controls
No statistical differences between automated and manual MRPI values in all groups
Automated MRPI Se 93 (PSP)
Sp 97 (vs. PD), 94 (vs. HC)
Manual MRPI Se 90 (PSP)
Sp 100 (vs. PD), 94 (vs. HC)
3.0 T Automated MRPI Se 97 (PSP)
Sp 97 (vs. PD), 97 (vs. HC)
Manual MRPI Se 100 (PSP)
Sp 100 (vs. PD) 100 (vs. HC)
Mangesius et al. (2017) (manuscript in preparation) 81 clinically uncertain parkinsonism (including n = 15 who developed PSP and n = 11 who developed MSA) 1.5 T md c, ma, ma/pa-ratio, md/pd-ratioc and MRPI showed high overall diagnostic accuracy and specificity (over 80%) in distinguishing PSP from non-PSP neurodegenerative parkinsonism md Se 89 (PSP)
Sp 91 (vs. other groups), 91 (vs. PD), 92 (vs. MSA)
ma Se 68 (PSP)
Sp 87 (vs. other groups), 88 (vs. PD), 85 (vs. MSA)
md/pd-ratio Se 87 (PSP)
Sp 94 (vs. other groups), 94 (vs. PD), 96 (vs. MSA)
ma/pa-ratio Se 89 (PSP)
Sp 85 (vs. other groups), 82 (vs. PD), 95 (vs. MSA)
MRPI Se 87 (PSP)
Sp 86 (vs. other groups), 82 (vs. PD), 100 (vs. MSA)
Nicoletti et al. (2006a) MSA 16 (MSA-P 13, MSA-C 3)/PD 26/HC 14 1.5 T ↓ Average MCPd in MSA compared to PD and HC using T1-weighted sequences MCPd Se 100 (MSA)
100 (vs. PD and HC)
Massey et al. (2013) PSP 21/PD 10/MSA 10/HC 21. 3.0 T ↓ md c and reduced md/pd-ratioc in PSP compared to MSA-P, PD, and HC md Se 90 (PSP)
Sp 100 (vs. PD, MSA. HC)
md/pd-ratio Se 86 (PSP)
Sp 100 (vs. PD, MSA. HC)
Kim et al. (2015) PD 82/PSP 29 3.0 T md d and ma/pa ratio discriminated PSP from PD with similar discriminatory power
MRPI showed lower discriminatory power
md Se 86 (PSP)
Sp 54
AUC = 0.76
ma/pa ratio (Cosottini method) (Cosottini et al. 2007) Se 62 (PSP)
Sp 76
AUC = 0.75
ma/pa ratio (Oba method) (Oba et al. 2005) Se 72 (PSP)
Sp 64
AUC = 0.75
MRPI Se 93 (PSP-RS)
Sp 43
AUC = 0.69
Moller et al. (2017) PD 204/PSP 106/MSA-C 21/MSA-P 60/HC 73 1.5 and 3.0 T ↓ ma in PSP vs. all other groups
↓ pa in MSA-C, MSA-P, and PSP vs. PD and HC.
↓ ma/pa in PSP vs. all other groups
↑ ma/pa in MSA-C and MSA-P vs. PD and PSP
ma AUC = 0.90 (PSP vs. PD)
Se 75, Sp 82, AUC = 0.85 (PSP vs. MSA-P)
ma/pa Se 76, Sp 80, AUC = 0.84 (PSP vs. PD)
Se 76, Sp 80, AUC = 0.89 (PSP vs. MSA-P)
MRPI Se 64, Sp 64, AUC = 0.75 (PSP vs. PD)
Se 73, Sp 60, AUC = 0.80 (PSP vs. MSA-P)
Automated methods for quantitative MRI analysis
 Huppertz et al. (2016) PD 204, PSP 106, MSA-C 21, MSA-P 60 1.5 and 3.0 T Fully automated brain volumetry combined with SVM classification allowed for automated differentiation on single-patient level
Volume changes of midbrain, basal ganglia, and cerebellar peduncles had the largest relevance for classification
Atlas-based voxel-based volumetry combined with SVM classification Classifications between the groups resulted in balanced diagnostic accuracies ≥80%
 Scherfler et al. (2016) PSP 30/MSA 40/PD 40 of whom 40 presented with a clinically uncertain parkinsonism  Data were split into a training (n = 72) and a test set (n = 38) 1.5 T Volume segmentation of subcortical brain regions followed by a machine-learning method-derived classification algorithm (i.e. C4.5 decision tree algorithm)
Most discriminative regions include the volume of the midbrain, followed by cerebellar GM and putamen
Diagnostic accuracy of the fully automated method for quantitative MRI analysis was 97% for the separation of PD vs. MSA or PSP, by contrast to the clinical diagnostic accuracy of 63% based on validated clinical consensus criteria at the time of MRI
Midbrain, putaminal and cerebellar GM volume Se 90 (PSP), 100 (MSA), 100 (PD)
Sp 100

APD atypical parkinsonian disorders, Se sensitivity, Sp specificity, AUC area under the curve; ↑ significant higher, ↓ significant lower, T tesla, MSA multiple system atrophy, MSA-P parkinsonian variant of MSA, MSA-C cerebellar variant of MSA, PD Parkinson’s disease, PSP progressive supranuclear palsy, HC healthy controls, MRI magnetic resonance imaging, VBM voxel-based morphometry, CC corpus callosum, WM white matter, GM grey matter, MCP middle cerebellar peduncle, SCP superior cerebellar peduncle, MRPI magnetic resonance parkinsonism index, m d midbrain diameter, m a midbrain area, p d pontine basis diameter, p a pontine area, SCP d superior cerebellar peduncle diameter, MCP d middle cerebellar peduncle diameter, m d /p d -ratio md to pd ratio, m a /p a -ratio ma to pa-ratio, p a /m a ratio pa to ma ratio, MCP d /SCP d MCPd to SCPd ratio, TIV total intracranial volume, SVM support vector machine, R2*  T2* relaxation rate

aNo PD patient was classified as having MSA-P or vice versa; however, three of the PD patients were classified as having MSA-C or PSP; discrimination of patients with MSA from PSP was poor

bDiagnostic accuracy values for planimetric measurements of regional brain structures are highest in PSP; therefore, sensitivity values were primarily given for PSP

cThese diameters were obtained by placing elliptical regions of interest in the midbrain and pontine basis in the midsagittal slice, and obtaining the maximal measurement perpendicular to the major axis of the ellipse

dAs obtained at the mid-mammillary-body level